Tokyo, Japan

Yuki Niimi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuki Niimi: Innovator in Cell Culture Technology

Introduction

Yuki Niimi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cell culture technology, particularly in the differentiation of pluripotent stem cells. His innovative approaches have the potential to advance research in regenerative medicine and developmental biology.

Latest Patents

Yuki Niimi holds a patent for a novel cell culture method and an automatic cell culture apparatus. This patent describes a method for inducing differentiation of pluripotent stem cells into trophoblasts. The process involves three key steps: first, culturing the pluripotent stem cells in the presence of a ROCK inhibitor; second, culturing the cells without the ROCK inhibitor; and finally, culturing the cells again in the presence of the ROCK inhibitor. This method allows for effective adherence to a cell culture substrate, which includes a planar mesh, throughout the entire process. He has 1 patent to his name.

Career Highlights

Yuki Niimi is currently employed at Hitachi, Ltd., where he continues to develop innovative solutions in cell culture technology. His work has garnered attention for its potential applications in various scientific fields, including tissue engineering and cellular therapies.

Collaborations

Yuki collaborates with talented colleagues, including Hiroko Hanzawa and Maiko Tanabe. Their combined expertise enhances the research and development efforts at Hitachi, Ltd.

Conclusion

Yuki Niimi's contributions to cell culture technology exemplify the impact of innovative thinking in scientific research. His patented methods and ongoing work at Hitachi, Ltd. position him as a key figure in advancing the field of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…